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Mother-to-child transmission (MTCT) contributes significantly to 
the incidence of HIV in sub-Saharan Africa and the rising number 
of children contracting HIV. In 2007 it was estimated that about 
300 000 of South Africa’s 5.5 million HIV-infected persons were 
children;1 this rose to 330 000 of 5.6 million in 2009.2
Prevention of mother-to-child transmission (PMTCT) strategies 
include the South African PMTCT programme that incorporates 
interventions antepartum, during labour and delivery, and 
postpartum.3,4 Despite comprehensive guidelines, service and patient-
related challenges compromise the effectiveness of the PMTCT 
programme, leading to the identification of children with previously 
undiagnosed HIV infection at public health facilities. These challenges 
include suboptimal PMTCT programme coverage, late presentation 
for the first antenatal visit, maternal seroconversion after the first 
visit with insufficient repeat testing in late pregnancy, and suboptimal 
postpartum follow-up.5 
The coverage of antiretroviral (ARV) prophylaxis and antiretroviral 
therapy (ART) initiation remains inadequate. The coverage of short-
course zidovudine is poorly documented. The national coverage for 
single-dose nevirapine between 2007 and 2008 was 76%,6 and a study 
in Cape Town reported that treatment was initiated in only 51% of 
pregnant women eligible for ART.7 
An opportunity for prevention is missed when undiagnosed HIV-
positive pregnant women are not identified by services. Booking 
should optimally occur at 14 weeks’ gestation and HIV status tested 
at the initial visit. Patients who refuse testing should be counselled 
to test at subsequent visits. Repeat HIV testing at 32 - 34 weeks for 
women who test negative in early pregnancy is national PMTCT 
policy.4 However, this is often poorly implemented. In Botswana, 
a study attributed 43% of all MTCT of HIV to seroconversion in 
late pregnancy and postpartum,8 highlighting the increased risk of 
unknown MTCT without re-testing. 
Low coverage of postpartum follow-up services creates more 
opportunities for MTCT. National and Western Cape province 
PMTCT guidelines include repeat testing for HIV-exposed children 
who tested negative at 6 weeks.3,4,9,10 In the case of breastfed infants, 
this is performed 6 weeks after breast-feeding is ceased. National 
guidelines also provide for re-testing of all HIV-exposed children 
at 18 months of age, but Cape Town City Health data show that few 
repeat tests are done.5 Furthermore, the risk of MTCT increases if 
mothers contract HIV postpartum; therefore, health services may not 
identify children with HIV in good time. 
We explored the acceptability and feasibility of routine HIV 
screening in children at primary healthcare clinics to ascertain the 
proportion of previously undiagnosed HIV-positive children aged 
17 - 24 months accessing curative and routine child healthcare 
services. 
Methods
This was an exploratory, facility-based cross-sectional study in the 
western sub-district of Cape Town. Primary healthcare facilities 
offering immunisation services (Du Noon, Albow Gardens, Vanguard 
and Langa) were non-randomly selected based on clinic size.
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Objectives. To explore the acceptability and feasibility of routine 
HIV screening in children at primary healthcare clinics and 
ascertain the prevalence of previously undiagnosed HIV infection 
in 17 - 24-month-old children accessing curative and routine 
services.
Methods. A survey was conducted in 4 primary health clinics 
in the western sub-district of Cape Town. Rapid HIV screening of 
17 - 24-monthold children was performed for consenting caregiver-
child pairs. Data on demographics, child health and antenatal 
history were collected using questionnaires.
Results. During recruitment, 358 children (72%) were tested for 
HIV infection. Most of the children (95.8%) were accompanied 
by a parent. The prevalence of reported HIV exposure among 
children was 21% (107/499). Of these, 3 had previously confirmed 
HIV infection; 1 was reportedly confirmed by a 6-week HIV test, 
and the other 2 probably contracted the virus via late postpartum 
transmission. The overall transmission rate was 3.5% (3/86) and the 
confirmed proportion of HIV-infected children was 0.8% (3/361). 
No previously unknown HIV infection was detected.
Conclusions. Programmes to prevent mother-to-child 
transmission are effective, but at-risk infants who test negative at 6 
weeks should be monitored for subsequent seroconversion. Parents 
of HIV-exposed infants are more likely to permit (re)testing of 
their infants than those whose offspring are not at risk. Routine 
HIV testing of children is feasible and acceptable at primary 
level, but may require additional resources to achieve universal 
coverage. Routine screening at an earlier age may detect previously 
undiagnosed HIV infection.
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Fieldworkers recruited all 
patients aged 17 - 24 months 
as they arrived to access health 
services. Paediatric HIV clinics 
were excluded from the study, 
but patients on HIV registers 
seeking other curative or routine 
health services were eligible. 
No sample size calculations 
were performed due to the 
exploratory nature of the study. 
The target recruitment number 
of 500 patients, realised between 
September 2010 and February 
2011, was based on Cape 
Town City Health statistics 
for the number of children 
accessing routine 18-month 
immunisation services over 3 
months.
Pre-consent eligibility was 
determined and demographic data of all potential participants 
were collected from caregivers (biological parents or legal/usual 
guardians). A PMTCT questionnaire administered to all eligible 
consenting caregivers covered maternal HIV status, antenatal history, 
child HIV testing and infant feeding. 
Healthcare providers (HCPs) provided the required consultation 
to children and their caregivers. To facilitate routine screening, 
HCPs implemented a streamlined approach to provider-initiated 
HIV counselling and testing (PICT).11 PICT was introduced prior 
to commencement of the study and all healthcare workers were 
trained accordingly. The Abbott Determine HIV antibody test was 
used to detect HIV infection. Known HIV-positive children were not 
screened. Caregivers could decline the testing of their children even 
in the case of prior consent.
Data were captured into a secure Microsoft Access database, 
validated and audited to ensure quality. Data analysis was performed 
using STATA Data Analysis and Statistical Software (release 11).
This was a non-anonymous study at primary healthcare facilities. 
Ethical approval was granted by the Health Sciences Research 
Ethics Committee at the University of Cape Town. Approval was 
also obtained from Cape Town City Health and the Western Cape 
Department of Health.
Results
During recruitment, 567 caregiver-child pairs were identified as 
potential participants (Fig. 1); 91% of caregivers were able to 
give legal consent but 3% declined, making the final number of 
participant pairs 499. A parent accompanied 95.8% (478/499) of 
children, including 97.2% (104/107) of HIV-exposed children and 
95.4% (374/392) of non-exposed children.
Ninety-nine per cent of pregnancies had been booked for delivery 
in an obstetric unit or hospital. The reported HIV prevalence of 
mothers was 21% (107/499). All except for 3 HIV infections were 
detected at early booking; these women tested negative at first 
booking, testing positive in late pregnancy, shortly post-partum and 
at recruitment, respectively. To their knowledge, 87% of all HIV-
infected mothers had been on the PMTCT programme.
During recruitment, 72% of infants (358/499) were tested for HIV. 
The highest uptake of infant testing was in known HIV-positive 
mothers (83/107; 77.6%), followed by known HIV-negative mothers 
(267/368; 72.6%) (Fig. 1). The lowest uptake was in mothers of 
unknown or undisclosed status (8/24; 33.3%), which differed from 
the expected trend for random refusal to test (Table 1). An overall chi-
squared test confirmed a significant association between the uptake 
of HIV testing and maternal HIV status (χ2(2)=21.07, p<0.001). 
There was no significant difference in testing between HIV-positive 
and HIV-negative participants who disclosed maternal HIV status 
(χ2=2.66, p=0.103). However, a significantly lower uptake of testing 
was found by those participants whose HIV status was unknown or 
undisclosed compared with known HIV-infected mothers (χ2=21.40, 
p<0.001) and those known to be uninfected (χ2=16.55, p<0.001).
No previously unknown HIV infection was detected. However, 
87.9% (94/107) of known HIV-positive mothers (18.8% of total 
cohort) reported that their children were screened with HIV 
polymerase chain reaction (PCR) tests at 6 weeks. Of these, 1 child 
tested positive. In addition, 79 children had been tested for HIV in 
infancy (some were exposed to HIV but tested negative at 6 weeks). 
Two tested HIV-positive and were diagnosed with HIV infection in 
the 2 months preceding recruitment, because of intercurrent illness. 
One of these tested negative at 6 weeks. The other accessed PMTCT 
services in a neighbouring country, but it is uncertain whether the 
child had a 6-week HIV PCR test. The 6-week HIV transmission rate 
in this sample was 1.1% (1/94), the confirmed overall transmission 
rate was 3.5% (3/86), and the proportion of HIV-infected children 
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Table 1. Comparison of observed (and expected) frequencies 
for HIV testing by maternal status
Maternal status Screened for HIV
Yes No Total
HIV-positive 83 21 104*
(75.1) (28.9)
HIV-negative 267 101 368
(265.6) (102.4)
Unknown/undisclosed† 8 16 24
(17.3) (6.7)
Total 358 138 496*
*3 children with confirmed HIV-infection not screened for HIV.
†Chi-square test of association significant (χ2(2)=21.07, p<0.001) due to testing patterns 
in this group.
Fig. 1. Summary of participants from recruitment to HIV testing.
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(among those with confirmed HIV status) between 17 - 24 months 
of age was 0.8% (3/361). The HIV status of 28% (138) of the children 
remained unknown as they were not tested.
Ninety-two per cent (98/107) of HIV-exposed infants were 
reportedly never breastfed. The remaining 9 (8%) were exclusively 
breastfed (EBF) in the first 6 months. After this time, breast-feeding 
was ceased in favour of replacement feeding (formula and/or solid 
food) in 7 of the infants and 2 mothers reported mixed feeding. In 
the latter, the status of 1 mother was previously unknown; she tested 
HIV-positive on the day of recruitment, but her child tested negative. 
The 2 children diagnosed with HIV in the 2 months preceding 
recruitment were EBF in the first 6 months and replacement-fed 
thereafter. One was reported to be HIV-negative at 6 weeks (PCR 
test), therefore infection may have been transmitted via breast-
feeding.
Discussion
The percentage of HIV-exposed infants (21%) was in keeping with 
the antenatal HIV prevalence reflected by a survey in 2009.12 Overall, 
this was 18.2% (95% CI 17.0 - 19.3) and 17.0% (95% CI 14.1 - 20.0) 
in the Metro and western sub-districts, respectively. The higher 
result in our study may have been attributed to the smaller sample 
size, or the higher proportion of at-risk infants returning to follow-
up clinics compared with those not at risk. It is more likely that our 
findings reflect the high prevalence of HIV in the low socioeconomic 
profile areas of Du Noon, Langa and Bonteheuwel. A comparable 
sub-district of Klipfontein has an HIV exposure rate of 24% (CI 
21.0 - 27.1).
We found a low burden of HIV infection (0.8%) in 17 - 24-month- 
old children attending clinics for curative and routine visits. To our 
knowledge, this is the first published study of HIV burden in this age 
group in South Africa. This prevalence is lower than that estimated 
in the 2008 Human Science Research Council survey (1.1% among 
children aged 2 - 14 years in the Western Cape).13 While this could 
attest to effective PMTCT programme coverage, it is unclear whether 
the overall population is represented in these findings. The reported 
6-week transmission rate of 1.1% was lower than the 2008/2009 
provincial estimate of 4.5%.14 This could be attributed to differences 
in the study sites or because of participant selection bias. 
Moreover, this raises questions about the patterns of access to 
health services among HIV-infected children. Up to 40% of HIV-
exposed children may be lost to follow-up services by 18 months 
of age.15 The median survival time of untreated perinatally infected 
children is 1.1 years.16 HIV-related mortality rates are very high in the 
first year of life, especially when ART is not initiated early.17 Children 
in this age group with unknown HIV infection may present with 
advanced disease at secondary and tertiary healthcare facilities before 
18 months of age. One of the 2 HIV-positive children diagnosed in 
the 2 months preceding recruitment in this study was diagnosed at 
a secondary level institution. Furthermore, HIV-infected children 
who survive hospital admission may be followed up and immunised 
in hospital-based services before referral to primary level services. 
Three of the 4 study clinics had a designated HIV clinic (excluded 
from recruitment) which may have provided routine health services 
including immunisations. Therefore, the low burden of HIV in 
this study does not account for HIV-infected children being sick, 
accessing health services elsewhere, or dying before their 18 month 
immunisation visit. 
The overall transmission rate for participants was 3.5% (3 cases). 
This included a case of perinatal transmission (6-week HIV PCR 
test proved positive), and at least 1 case of postpartum transmission 
probably from breast-feeding (reported negative 6-week HIV PCR 
test). The age of the participant in the third case indicated that HIV 
contraction was also possibly via breast-feeding.
In this study, routine HIV testing of children was feasible and 
acceptable. Despite preconceptions of high rates of caregiver rotation 
at child health services, a high proportion of children accessed 
health services with a biological parent. This argues against routine 
HIV testing not being feasible due to legal issues when children are 
not accompanied by a guardian. The high rates of consent in this 
study reflect the acceptability of an HIV testing service to clients, 
as demonstrated in KwaZulu-Natal and Limpopo provinces.18 Our 
research also suggests that mothers are not opposed to PICT, which 
is part of the HIV component of the South African Integrated 
Management of Childhood Illness guidelines.
Managers at the research sites commented that the testing 
of children led some mothers to confirm their own status. The 
implementation of a more efficient approach to testing is valuable 
in integrating and streamlining a service with a sizeable impact on 
maternal and child health.11
Despite consenting to the study, only 72% of participants were 
tested for HIV. Reasons for declining testing were not determined. 
Researchers reported that some mothers retracted consent to avoid 
the trauma of additional procedures such as HIV testing on the 
same day as immunisations. This may indicate a need for additional 
resources to allow universal coverage. 
This does not account for the discrepancy in consent to testing 
according to maternal HIV status. Known HIV-positive mothers 
were more likely to consent to the testing of their children (78%) 
than uninfected mothers (73%). The low rate of consent by 
mothers of unknown or undisclosed HIV status (33.3%) may 
indicate that known HIV-positive mothers perceive more benefit 
in re-testing their children. This could reflect a lack of knowledge 
of the possibility of late pregnancy and postnatal maternal 
acquisition of HIV. Mothers who have never been tested or refuse 
to acknowledge their results may be in denial about their HIV 
status or risk, thereby denying their children HIV screening and 
possible early detection. 
Our results question whether routine screening of HIV in children 
should occur at all, and if so, whether at 18 months or at earlier 
routine healthcare visits. Two of the 3 confirmed cases of HIV were 
detected within 2 months of the study and could have been detected 
by earlier screening. Many children still present with undiagnosed 
HIV in the first year of life. Earlier diagnosis would lower HIV 
morbidity and mortality,17 especially in perinatal MTCT.16
It is important to consider the decline in access to services after the 
first year of life.15,19 Routine immunisation coverage in the Western 
Cape drops to just over one half by 18 months of age.19 Mothers 
do not wish to have invasive procedures (immunisations) and 
investigations (HIV test) performed on the same day; therefore, it 
would be preferable to link HIV testing to other routine health visits. 
Many mothers, however, only bring their children for immunisation 
visits. Furthermore, the Department of Health has called for the 
cessation of the free distribution of milk formula at health services, 
instead promoting EBF for the first 6 months of life – regardless of 
maternal HIV-status – together with ART provision to HIV-infected 
mothers and their infants.20 It may be advisable to recommend 
routine HIV tests after 7 months of age (e.g. at 9 months), but this 
does not take into account HIV-positive mothers who continue 
breast-feeding after 9 months of age whose children may require yet 
another follow-up test. 
Since the additional cases detected arose in the HIV-exposed 
group, it is important to question whether there is any value in 
screening children of HIV-negative women. There may be more 
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benefit to screening HIV-exposed children and previously HIV-
negative women to detect seroconversion and test the infants 
accordingly.
The generalisability of the findings is hindered by the study’s 
limitations. As an exploratory study, the sample size and study area 
were both small. These are unlikely factors in other programmes in 
the province and country. The probability of participant selection 
bias should be mentioned, including an apparent ‘healthy child’ effect 
at primary healthcare level. Furthermore, given the high rates of 
institutional booking of pregnancies and deliveries in this study, the 
caregiver-child pairs may have been more likely to access postnatal 
public health services than those who do not access antenatal care or 
deliver at health facilities. 
Despite these limitations, lessons can be learned in terms of 
best practice, opportunities to be seized, and what these mean for 
the PMTCT programme and child health. The low burden of HIV 
demonstrates an effective PMTCT programme, but testing protocols 
must identify HIV infection not detected at 6 weeks, especially 
in breastfed children. Routine PICT is an acceptable and feasible 
service. The effect of routine HIV testing at 7 - 9 months of age 
should be assessed. 
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